Near-lockdown in the Bay Area ‘ratchets up’ challenges for local biotechs and labs
The Bay Area's “shelter in place” order, which aims to slow the spread of the #coronavirus, is ushering in a new reality for biopharma companies and biomedical labs.
At the stroke of midnight on Tuesday morning, seven counties in the San Francisco Bay Area went into near-lockdown — ushering in a new reality for biopharma companies and biomedical labs.
The , which aims to slow the spread of the coronavirus by mostly confining residents to their homes for at least the next three weeks, offers significant leeway for medical research. Employees of pharma and biotech companies are to travel to and from work. So too is anyone working in “health care operations,” which leaves
